4/9
08:10 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $37.00 price target on the stock, down previously from $50.00.
Medium
Report
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $37.00 price target on the stock, down previously from $50.00.
4/1
09:04 am
gmab
Genmab A/S (NASDAQ: GMAB) was downgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "underperform" rating.
Low
Report
Genmab A/S (NASDAQ: GMAB) was downgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "underperform" rating.
4/1
04:53 am
gmab
Genmab downgraded to Underperform from Market Perform at Bernstein
Low
Report
Genmab downgraded to Underperform from Market Perform at Bernstein
4/1
04:53 am
gmab
Genmab downgraded to Underperform from Market Perform at Bernstein
Low
Report
Genmab downgraded to Underperform from Market Perform at Bernstein
3/11
11:20 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
3/11
11:20 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
3/11
08:09 am
gmab
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
3/11
08:09 am
gmab
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
3/10
05:54 pm
gmab
Genmab upgraded to Outperform from Market Perform at William Blair
Medium
Report
Genmab upgraded to Outperform from Market Perform at William Blair
3/10
05:54 pm
gmab
Genmab upgraded to Outperform from Market Perform at William Blair
Medium
Report
Genmab upgraded to Outperform from Market Perform at William Blair
2/13
08:06 am
gmab
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at BNP Paribas from a "strong sell" rating to a "hold" rating.
Medium
Report
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at BNP Paribas from a "strong sell" rating to a "hold" rating.
2/13
07:20 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
2/13
07:15 am
gmab
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $27.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $27.00 price target on the stock.
2/13
06:14 am
gmab
Genmab upgraded to Outperform from Market Perform at Leerink
Low
Report
Genmab upgraded to Outperform from Market Perform at Leerink
2/11
04:46 am
gmab
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
Low
Report
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
2/11
04:46 am
gmab
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
Low
Report
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
2/11
04:46 am
gmab
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
Low
Report
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
2/11
04:27 am
gmab
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
Low
Report
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
2/11
04:27 am
gmab
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
Low
Report
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
2/11
04:27 am
gmab
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
Low
Report
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
1/23
08:02 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.